Mostafa Kamal insider trades: Magellan Health (MGLN) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mostafa reports to the SEC
Open-market buys and sales
17 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 9, 2020 | MGLN | ↓ Sell | 2,793 | $79.69 | $223K | Direct | Dec 11, 2020 (2d) |
| Nov 16, 2020 | MGLN | ↓ Sell | 20,885 | $84.82 | $1.8M | Direct | Nov 17, 2020 (1d) |
| Nov 10, 2020 | MGLN | ↓ Sell | 6,000 | $81.57 | $489K | Direct | Nov 12, 2020 (2d) |
| Nov 5, 2020 | MGLN | ↓ Sell | 7,023 | $79.88 | $561K | Direct | Nov 6, 2020 (1d) |
| Oct 16, 2020 | MGLN | ↓ Sell | 183 | $79.87 | $15K | Direct | Oct 20, 2020 (4d) |
| Dec 9, 2019 | MGLN | ↓ Sell | 16,766 | $78.72 | $1.3M | Direct | Dec 11, 2019 (2d) |
| Apr 2, 2018 | MGLN | ↓ Sell | 1,666 | $106.20 | $177K | Direct | Apr 4, 2018 (2d) |
| Mar 5, 2018 | MGLN | ↓ Sell | 15,428 | $99.04 | $1.5M | Direct | Mar 6, 2018 (1d) |
| Dec 4, 2017 | MGLN | ↓ Sell | 2,180 | $92.00 | $201K | Direct | Dec 6, 2017 (2d) |
| Nov 1, 2017 | MGLN | ↓ Sell | 1,154 | $92.00 | $106K | Direct | Nov 2, 2017 (1d) |
| Sep 28, 2017 | MGLN | ↓ Sell | 4,848 | $85.76 | $416K | Direct | Sep 29, 2017 (1d) |
| Sep 27, 2017 | MGLN | ↓ Sell | 19,126 | $85.33 | $1.6M | Direct | Sep 28, 2017 (1d) |
| Sep 15, 2017 | MGLN | ↓ Sell | 2,961 | $84.00 | $249K | Direct | Sep 18, 2017 (3d) |
| Sep 13, 2017 | MGLN | ↓ Sell | 604 | $83.00 | $50K | Direct | Sep 14, 2017 (1d) |
| Sep 11, 2017 | MGLN | ↓ Sell | 670 | $83.00 | $56K | Direct | Sep 12, 2017 (1d) |
| Sep 8, 2017 | MGLN | ↓ Sell | 6,267 | $81.53 | $511K | Direct | Sep 11, 2017 (3d) |
| Sep 7, 2017 | MGLN | ↓ Sell | 2,190 | $81.07 | $178K | Direct | Sep 8, 2017 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mostafa Kamal's insider trades
Mostafa Kamal is CEO, Magellan Rx Management at Magellan Health (MGLN). Since Sep 7, 2017, Mostafa has reported no open-market purchases and 17 sales worth $9.5M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (23 filings), shares withheld for taxes (7 filings), grants and awards (7 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MGLN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.